TABLE 1.
Classification and major features of stem cells reported in glioma therapy.
Stem cell | Defining criteria | Source/Niche | Linage |
Pluripotent stem cells: capacity to differentiate into any cell of all three germ layers | |||
Embryonic stem cells (ECSs) | Markers of pluripotency as found in ICM cells: Transcription factors: Oct4, Nanog, Rex-1 Cell surface markers: SSEA-3, SSE-A4, TRA-1-60, TRA-1-81, alkaline phosphatase |
Blastocyst Morula Growth-arrested embryos Somatic cell nuclear transfer Single blastomere | As defined by pluripotency |
Induce pluripotent stem cells (iPSCs) | Essentially the same than ECS markers | Reprogrammed adult somatic cells—usually fibroblasts or skin cells. | As defined by pluripotency given than iPSC are functionally equivalent to ECS |
Multipotent stem cells: capacity to differentiate into cells of one of the three germ layers | |||
Neural stem cells (NSCs) |
Positive: GFAP, CD133, CD184, and Nestin, Sox1, Sox2, and Pax6 Negative: CD271, CD44, CD24 Immune profile: Absent HLA II |
Subependymal zone (SEZ)—lining the lateral ventricles Dentate gyrus of the hippocampus *Obtained from fetal and adult mammals | Neurons Oligodendrocytes Astrocytes Ependymal cells |
Mesenchymal stem cells (MSCs) | MSC must comply with ISCT criteria: Positive (>95% +): CD105, CD73, CD90 Negative (<2% –): CD45, CD34, CD14 or CD11b, CD79α, or CD19, HLA DR Adherence to plastic in standard culture conditions In vitro differentiation to osteoblast, adipocytes, and chondroblasts. Immune profile: Absent HLA II |
Adult tissues: adipose tissue, bone marrow, peripheral blood, dental pulp, ligamentum flavum, synovium, endometrium, sweat glands, and milk Fetal tissues: umbilical cord, umbilical cord blood, Wharton jelly, amniotic fluid, chorionic villi, and placenta |
Osteoblast Adipocytes Chondroblast *Differentiation into ectodermal and endodermal linages has also been reported |
Hematopoietic stem cells (HMSs) |
Negative: CD45R/B220 (B cells), Gr-1 (granulocytes), Mac-1 (macrophages), Ter-119 (erythrocytes) and CD4/CD8 (lymphocytes)—for phenotypic enrichment. Positive: Sca-1, c-Kit, CD150 *They appear as side population in dye exclusion assays due to the high expression of MDR pumps |
Adult tissues: bone marrow, peripheral blood Non-adult tissues: umbilical cord blood, yolk sac, liver, spleen |
Hematopoietic cells |
IMC, inner mass cells; MDR, multidrug resistance.